
Robert E. Mosser
Examiner (ID: 16617, Phone: (571)272-4451 , Office: P/3714 )
| Most Active Art Unit | 3715 |
| Art Unit(s) | 3714, 3715, 3713, 3712 |
| Total Applications | 839 |
| Issued Applications | 347 |
| Pending Applications | 141 |
| Abandoned Applications | 372 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12247283
[patent_doc_number] => 09920049
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-20
[patent_title] => 'Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection'
[patent_app_type] => utility
[patent_app_number] => 15/349343
[patent_app_country] => US
[patent_app_date] => 2016-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 25120
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15349343
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/349343 | Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection | Nov 10, 2016 | Issued |
Array
(
[id] => 11618233
[patent_doc_number] => 20170128421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-11
[patent_title] => 'Premix formulation for parenteral use and packaging thereof'
[patent_app_type] => utility
[patent_app_number] => 15/348374
[patent_app_country] => US
[patent_app_date] => 2016-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6189
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15348374
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/348374 | Premix formulation for parenteral use and packaging thereof | Nov 9, 2016 | Abandoned |
Array
(
[id] => 16244789
[patent_doc_number] => 10744113
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-18
[patent_title] => Use of chromone derivative as pharmaceutical composition for prevention and treatment of fibrosis using EMT inhibitory activity
[patent_app_type] => utility
[patent_app_number] => 15/347795
[patent_app_country] => US
[patent_app_date] => 2016-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9293
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15347795
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/347795 | Use of chromone derivative as pharmaceutical composition for prevention and treatment of fibrosis using EMT inhibitory activity | Nov 9, 2016 | Issued |
Array
(
[id] => 13504545
[patent_doc_number] => 20180303815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => COMBINATION OF BCL-2 INHIBITOR AND MEK INHIBITOR FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 15/767914
[patent_app_country] => US
[patent_app_date] => 2016-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16412
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15767914
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/767914 | Combination of Bcl-2 inhibitor and MEK inhibitor for the treatment of cancer | Nov 2, 2016 | Issued |
Array
(
[id] => 11441848
[patent_doc_number] => 20170042869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'Methods for limiting acute kidney injury'
[patent_app_type] => utility
[patent_app_number] => 15/334770
[patent_app_country] => US
[patent_app_date] => 2016-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5304
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15334770
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/334770 | Methods for limiting acute kidney injury | Oct 25, 2016 | Abandoned |
Array
(
[id] => 11554161
[patent_doc_number] => 20170100400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-13
[patent_title] => 'INHIBITORS OF INFLUENZA VIRUSES REPLICATION'
[patent_app_type] => utility
[patent_app_number] => 15/299757
[patent_app_country] => US
[patent_app_date] => 2016-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 115
[patent_figures_cnt] => 115
[patent_no_of_words] => 207834
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15299757
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/299757 | Inhibitors of influenza viruses replication | Oct 20, 2016 | Issued |
Array
(
[id] => 11441878
[patent_doc_number] => 20170042900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'PREVENTIVE AND/OR THERAPEUTIC AGENT OF IMMUNE DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/297196
[patent_app_country] => US
[patent_app_date] => 2016-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 42910
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15297196
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/297196 | Preventive and/or therapeutic agent of immune disease | Oct 18, 2016 | Issued |
Array
(
[id] => 11401692
[patent_doc_number] => 20170022227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-26
[patent_title] => 'CRYSTALLIZATION METHOD AND BIOAVAILABILITY'
[patent_app_type] => utility
[patent_app_number] => 15/288139
[patent_app_country] => US
[patent_app_date] => 2016-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 70944
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15288139
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/288139 | Crystallization method and bioavailability | Oct 6, 2016 | Issued |
| 15/283422 | 5-SUBSTITUTED 2, 4-THIAZOLIDINEDIONES (THIOHYDANTOINS), PSEUDOTHIOHYDANTOINS, AND PROPSEUDOTHIOHYDANTOINS FOR USE AS ANTIVIRAL AND ANTIFUNGAL AGENTS | Oct 1, 2016 | Abandoned |
Array
(
[id] => 11381482
[patent_doc_number] => 20170007538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-12
[patent_title] => 'INJECTION PREPARATION AND METHOD FOR PRODUCING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/269989
[patent_app_country] => US
[patent_app_date] => 2016-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14093
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15269989
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/269989 | Injection preparation and method for producing the same | Sep 19, 2016 | Issued |
Array
(
[id] => 13674995
[patent_doc_number] => 20160376231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => ANTIVIRAL COMPOUNDS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 15/262075
[patent_app_country] => US
[patent_app_date] => 2016-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7867
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15262075
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/262075 | Antiviral compounds and methods | Sep 11, 2016 | Issued |
Array
(
[id] => 13635179
[patent_doc_number] => 09844539
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-19
[patent_title] => Compounds and methods for kinase modulation, and indications therefor
[patent_app_type] => utility
[patent_app_number] => 15/260042
[patent_app_country] => US
[patent_app_date] => 2016-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35631
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15260042
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/260042 | Compounds and methods for kinase modulation, and indications therefor | Sep 7, 2016 | Issued |
Array
(
[id] => 12171011
[patent_doc_number] => 09889127
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-13
[patent_title] => 'Method of inhibiting mutant C-KIT'
[patent_app_type] => utility
[patent_app_number] => 15/255912
[patent_app_country] => US
[patent_app_date] => 2016-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 5555
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15255912
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/255912 | Method of inhibiting mutant C-KIT | Sep 1, 2016 | Issued |
Array
(
[id] => 11455849
[patent_doc_number] => 20170049751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-23
[patent_title] => 'OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/254271
[patent_app_country] => US
[patent_app_date] => 2016-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 31199
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15254271
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/254271 | OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF | Aug 31, 2016 | Abandoned |
Array
(
[id] => 13383813
[patent_doc_number] => 20180243448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => DEVICES, KITS, AND METHODS FOR DETERMINING INEFFECTIVENESS OF ANESTHETICS
[patent_app_type] => utility
[patent_app_number] => 15/755127
[patent_app_country] => US
[patent_app_date] => 2016-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -69
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15755127
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/755127 | DEVICES, KITS, AND METHODS FOR DETERMINING INEFFECTIVENESS OF ANESTHETICS | Aug 25, 2016 | Abandoned |
Array
(
[id] => 11362791
[patent_doc_number] => 20170000772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-05
[patent_title] => 'SMALL MOLECULE MODULATORS OF PRB INACTIVATION'
[patent_app_type] => utility
[patent_app_number] => 15/237801
[patent_app_country] => US
[patent_app_date] => 2016-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14081
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15237801
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/237801 | SMALL MOLECULE MODULATORS OF PRB INACTIVATION | Aug 15, 2016 | Abandoned |
Array
(
[id] => 13672467
[patent_doc_number] => 20160374967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => ORGANIC THIOPHOSPHATE ANTIRETROVIRAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 15/235847
[patent_app_country] => US
[patent_app_date] => 2016-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14105
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15235847
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/235847 | ORGANIC THIOPHOSPHATE ANTIRETROVIRAL AGENTS | Aug 11, 2016 | Abandoned |
Array
(
[id] => 11421214
[patent_doc_number] => 20170029359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-02
[patent_title] => 'ANTIMICROBIAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/234592
[patent_app_country] => US
[patent_app_date] => 2016-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 15662
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15234592
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/234592 | ANTIMICROBIAL COMPOUNDS | Aug 10, 2016 | Abandoned |
Array
(
[id] => 15571449
[patent_doc_number] => 10576083
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-03
[patent_title] => Method of treating pulmonary arterial hypertension
[patent_app_type] => utility
[patent_app_number] => 15/230803
[patent_app_country] => US
[patent_app_date] => 2016-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3748
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15230803
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/230803 | Method of treating pulmonary arterial hypertension | Aug 7, 2016 | Issued |
Array
(
[id] => 13165555
[patent_doc_number] => 10098869
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-16
[patent_title] => Compounds for the treatment of cancers associated with human papillomavirus
[patent_app_type] => utility
[patent_app_number] => 15/231684
[patent_app_country] => US
[patent_app_date] => 2016-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 8919
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15231684
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/231684 | Compounds for the treatment of cancers associated with human papillomavirus | Aug 7, 2016 | Issued |